These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 16287762)

  • 41. Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis.
    Mikuls TR; Endo JO; Puumala SE; Aoun PA; Black NA; O'Dell JR; Stoner JA; Boilesen EC; Bast MA; Bergman DA; Ristow KM; Ooi M; Armitage JO; Habermann TM
    J Clin Oncol; 2006 Apr; 24(10):1597-602. PubMed ID: 16520462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
    Liang Y; Yang Z; Qin B; Zhong R
    Ann Rheum Dis; 2014 Jun; 73(6):1151-6. PubMed ID: 23687261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shared familial aggregation of susceptibility to autoimmune diseases.
    Hemminki K; Li X; Sundquist K; Sundquist J
    Arthritis Rheum; 2009 Sep; 60(9):2845-7. PubMed ID: 19714648
    [No Abstract]   [Full Text] [Related]  

  • 44. [Monoclonal gammopathy of uncertain significance in rheumatic disease].
    Broggini M; Cavallo A; Baratelli E; Volonté S; Crespi E; Cappelli A; Chelazzi G
    Recenti Prog Med; 1990 May; 81(5):306-9. PubMed ID: 2377807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
    Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
    Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoimmune disease aggregation in families with primary Sjögren's syndrome.
    Anaya JM; Tobon GJ; Vega P; Castiblanco J
    J Rheumatol; 2006 Nov; 33(11):2227-34. PubMed ID: 17086607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytical epidemiological studies using meta-analysis.
    Spector TD; Hochberg MC
    Br J Rheumatol; 1989; 28 Suppl 1():11-2; discussion 18-23. PubMed ID: 2819342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies.
    Dal Maso L; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2078-85. PubMed ID: 17119031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malignancy and autoimmunity.
    Bernatsky S; Ramsey-Goldman R; Clarke A
    Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parental history of lupus and rheumatoid arthritis and risk in offspring in a nationwide cohort study: does sex matter?
    Somers EC; Antonsen S; Pedersen L; Sørensen HT
    Ann Rheum Dis; 2013 Apr; 72(4):525-9. PubMed ID: 22586159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
    Cuttner J; Spiera H; Troy K; Wallenstein S
    J Rheumatol; 2005 Oct; 32(10):1884-7. PubMed ID: 16206341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Zonana-Nacach A; Santana-Sahagún E; Jiménez-Balderas FJ; Camargo-Coronel A
    J Clin Rheumatol; 2008 Apr; 14(2):74-7. PubMed ID: 18391674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea.
    Hsiao YH; Chen YT; Tseng CM; Wu LA; Lin WC; Su VY; Perng DW; Chang SC; Chen YM; Chen TJ; Lee YC; Chou KT
    Sleep; 2015 Apr; 38(4):581-6. PubMed ID: 25669189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome.
    Nielsen NM; Jørgensen KT; Pedersen BV; Rostgaard K; Frisch M
    Hum Reprod; 2011 Jun; 26(6):1555-9. PubMed ID: 21471158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
    Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
    J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.
    van den Borne BE; Landewé RB; Houkes I; Schild F; van der Heyden PC; Hazes JM; Vandenbroucke JP; Zwinderman AH; Goei The HS; Breedveld FC; Bernelot Moens HJ; Kluin PM; Dijkmans BA
    Arthritis Rheum; 1998 Nov; 41(11):1930-7. PubMed ID: 9811046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome.
    Liu K; Kurien BT; Zimmerman SL; Kaufman KM; Taft DH; Kottyan LC; Lazaro S; Weaver CA; Ice JA; Adler AJ; Chodosh J; Radfar L; Rasmussen A; Stone DU; Lewis DM; Li S; Koelsch KA; Igoe A; Talsania M; Kumar J; Maier-Moore JS; Harris VM; Gopalakrishnan R; Jonsson R; Lessard JA; Lu X; Gottenberg JE; Anaya JM; Cunninghame-Graham DS; Huang AJW; Brennan MT; Hughes P; Illei GG; Miceli-Richard C; Keystone EC; Bykerk VP; Hirschfield G; Xie G; Ng WF; Nordmark G; Eriksson P; Omdal R; Rhodus NL; Rischmueller M; Rohrer M; Segal BM; Vyse TJ; Wahren-Herlenius M; Witte T; Pons-Estel B; Alarcon-Riquelme ME; Guthridge JM; James JA; Lessard CJ; Kelly JA; Thompson SD; Gaffney PM; Montgomery CG; Edberg JC; Kimberly RP; Alarcón GS; Langefeld CL; Gilkeson GS; Kamen DL; Tsao BP; McCune WJ; Salmon JE; Merrill JT; Weisman MH; Wallace DJ; Utset TO; Bottinger EP; Amos CI; Siminovitch KA; Mariette X; Sivils KL; Harley JB; Scofield RH
    Arthritis Rheumatol; 2016 May; 68(5):1290-1300. PubMed ID: 26713507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.